Terminated PHASE4 INTERVENTIONAL 3-arm NCT00748371

Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration

Sponsor: Vanderbilt University

Updated 7 times since 2017 Last updated: Apr 10, 2017 Started: Jun 30, 2004 Primary completion: Feb 28, 2011 Completion: Feb 28, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding issue

Other terminated trials from Vanderbilt University

See all terminations from Vanderbilt University

This PHASE4 trial investigates Platelet Aggregation and is currently terminated or withdrawn. Vanderbilt University leads this study, which shows 7 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
May 2017 — Jun 2018 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vanderbilt University

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States